RADIO PHARMACEUTICALS: A TEACHER’S COMPREHENSIVE GUIDE
Welcome, future nuclear pharmacists and healthcare professionals!
Radio pharmaceuticals are a unique and fascinating class of drugs that combine pharmaceutical compounds with radioactive materials. These specialized products are used for both diagnostic and therapeutic purposes in modern medicine. As a pharmacy educator with years of experience teaching nuclear pharmacy, I have observed that students often find this topic challenging due to its interdisciplinary nature—requiring knowledge of both pharmacy and radiation physics.
In this comprehensive guide, I will walk you through the fundamentals of radio pharmaceuticals—from their ideal characteristics and handling procedures to storage, dispensing, disposal, and clinical applications. I will share practical insights from both classroom teaching and clinical nuclear pharmacy practice. By the end of this article, you will have a thorough understanding of how radio pharmaceuticals are used safely and effectively in healthcare. Let us begin our journey into the fascinating world of nuclear pharmacy.
Dpharmguru’s exam insights:
Radio pharmaceuticals are frequently tested in pharmacy exams. Remember: The radioactive portion releases radiation that scanners can measure, while the pharmaceutically active portion determines the activity that will be calculated. Key concepts include: physical half-life, gamma ray emission, specific activity, and the distinction between diagnostic and therapeutic applications. Pay special attention to Tc-99m—it is the most commonly used radio pharmaceutical!
6.1. RADIO PHARMACEUTICALS
Radio Pharmaceuticals are drugs that are attached to radioactive materials. The radioactive portion releases radiation that the scanner can measure, while the pharmaceutically active portion determines the activity that will be calculated. These specially designed products are used therapeutically for treatment and diagnosis. Their usage is very restricted and they are primarily used for diagnostic purposes.
Radio pharmaceuticals get distributed in the body and emit radiations. These radiations are photographed to detect internal injury, abnormal cell growth, etc. The radiation exposure is kept very low to ensure patient safety while obtaining valuable diagnostic information.
6.1.1. Ideal Characteristics of Radio Pharmaceuticals
The ideal characteristics of radio pharmaceuticals are as follows:
- Short Physical Half-Life: Radio pharmaceuticals should have a short physical half-life to minimize radiation exposure to patients.
- Elimination Half-Life: They are eliminated from the body with a half-life almost equivalent to the duration of the test, preventing further exposure.
- Pure Gamma Ray Emission: They emit pure gamma rays by isomeric transition, which are ideal for imaging.
- Monoenergetic Gamma Rays: They emit monoenergetic (approximately 150 keV) gamma rays for clear imaging.
- High Specific Activity: High specific activity ensures that only small amounts of material are needed.
- Rapid Localisation: They quickly and broadly localise at the target site for accurate diagnosis or therapy.
- Stable Daughter Nucleus: They deteriorate into a more stable daughter nucleus, reducing long-term radiation risk.
- Efficient Labelling: They readily and efficiently adhere to the chemical component at room temperature.
- Cost-Effective: They are low-cost doses per patient.
- Easy Preparation: They are easy to create or maintain at the hospital site.
Dpharmguru’s exam insights:
The ideal characteristics of radio pharmaceuticals are frequently tested. Remember the acronym “SPHERE” for key properties: Short half-life, Pure gamma emission, High specific activity, Excellent localisation, Rapid elimination. Tc-99m is the gold standard because it has a 6-hour half-life, emits 140 keV gamma rays, and is widely available from a molybdenum generator.
6.1.2. Handling of Radio Pharmaceuticals
The handling of radio pharmaceuticals should be done cautiously as they are toxic substances and may be harmful to living beings. Key handling practices include:
- Contamination Prevention: The radioactive material must not contaminate the working area.
- Spill Management: For liquid radioactive materials, use trays with absorbent tissue paper for absorbing any accidental spillage.
- Personal Protective Equipment: Rubber gloves must be used while handling liquid radioactive materials.
- Equipment Safety: Mouth-operated pipettes must not be used. Glass apparatus must be inactivated before use.
- Activity Reduction: Before disposition, radioactive material must have very low activity; otherwise, they are stored until the activity reduces to safer levels.
- Prohibited Activities: Smoking, eating, and drinking are strictly prohibited in the area of radioactive work.
- Proper Tools: Forceps must be used while handling the radioactive emitter.
- Shielding: Shielding devices should be used sufficiently to protect personnel from radiation.
6.1.3. Storage of Radio Pharmaceuticals
Radiopharmaceuticals are stored in airtight containers in a shielded place. This place should be organised as per the national and international regulations set forth for the storage of radioactive substances. Personnel should not be exposed to any primary or secondary emissions.
The containers of radio pharmaceuticals may become dark due to irradiation, although this does not indicate that the substance has degraded. Radioactive substances are suggested to be used within a short time period and the expiry period should also be clearly mentioned. The parenteral radiopharmaceuticals should not lose their purity during storage, thus, optimum storage conditions must be maintained.
6.1.4. Dispensing of Radio Pharmaceuticals
The dispensing procedure of radio pharmaceuticals involves several critical steps:
- Secure Dispensing: Dispensing should be secure, simple, and reliable. Ready-to-use kits or cold kits, which offer single or multiple doses and can be reconstituted by the addition of radionuclide at the time of intended use, have been a significant development.
- Sterile Preparation: Chemical reagents should be manufactured in a sterile setting using pyrogen-free raw materials and dispensed in single or multiple unit dose containers. Cold kit preparation should be terminally sterilised using an autoclave or membrane filtration.
- Restricted Dispensing: Radio Pharmaceuticals should not be dispensed to patients directly; rather, they should be dispensed to healthcare providers in hospitals or clinics and then administered to patients.
- Dose Calculation: The recommended dose should be determined based on the patient’s history, age, weight, surface area, etc.
- Record Keeping: Prescriptions should be dispensed in accordance with applicable pharmacy law and the necessary records should be maintained.
- Right Patient, Right Dose: Policies and procedures should be created to ensure that the prescribed drug dose is administered to the right patient at the right time through the recommended administration route.
- Good Radiation Practices (GRP): To minimise unnecessary and avoidable radiation exposure, Good Radiation Practices should be adhered to carefully during operations with unrelated sources.
Labelling Requirements
Numerous regulatory organisations have authority over radiopharmaceuticals labelling. For the labelling of the inner container (syringe or vial) and the outer shielding (syringe or vial shielding), the standards should be considered as minimum requirements.
Information on Inner Container Label:
- Standard radiation symbol
- “Caution—Radioactive Material” warnings
- Patient’s name or unique identity (for therapeutic and blood products)
- Radionuclide and chemical form (generic name)
- Radioactivity on the calibration date and time
Information on Outer Shielding Label:
- Standard radiation symbol
- “Caution—Radioactive Material” warnings
- Patient name/identifier (for therapeutic and blood products)
- Radionuclide and chemical form (generic name)
- Radioactivity on the calibration date and time
- Dispensed volume or quantity (e.g., 2 capsules)
- Appropriate expiry date or Beyond Use Date (BUD) and handling/storage directions
- Administration route
Dpharmguru’s exam insights:
Labelling of radiopharmaceuticals is strictly regulated. Remember: Inner container labels include the radiation symbol, “Caution—Radioactive Material,” patient identifier, radionuclide, and calibration data. Outer shielding labels include all of the above plus dispensed volume, expiry date, and administration route. These requirements are frequently tested in exams!
6.1.5. Disposal of Radio Pharmaceuticals
Emphasising mainly on protecting human health, the environment, and future generations, the overall philosophy for safe radioactive waste management in India is based on the concept of:
- Delay – Allowing radioactive decay to reduce activity
- Dilute and Disperse – Diluting to safe concentration levels
- Concentrate and Contain – Concentrating for safe containment
- Recycle and Reuse – Recovering usable materials
Solid Wastes: Appropriate solid radioactive waste disposal is necessary to maintain human health and safety and the quality of environmental resources. At the Near Surface Disposal Facility (NSDF), waste disposal is performed in specially built engineering modules. High-level solid wastes are disposed of in Geological Disposal Facilities (GDF).
Liquid Wastes: Before being immobilised in an appropriate matrix, liquid radioactive waste streams are pre-treated using procedures like filtration, adsorption, chemical treatment, evaporation, ion exchange, and reverse osmosis.
Gaseous Wastes: Gaseous radioactive wastes are effectively treated at the source of generation by processes like adsorption on activated charcoal, absorption/scrubbing, and filtration using high-efficiency particulate air filters.
6.1.6. Applications of Radiopharmaceuticals
Radiopharmaceuticals can be used in two different ways for medical purposes:
1. Therapeutic Applications
The therapeutic effect of radiopharmaceuticals utilises the destructive features of radiations. These radiations destroy abnormally multiplied cells and further inhibit the formation of new cells and tissues. It is frequently used in the treatment of disorders like cancers which involve extensive cellular malfunction.
External Radiation Sources:
- Teletherapy Sources: Co-60, Cs-137, and neutral charged particles
- Surface Sources: Sr-90 and P-32 (Beta-emitters)
- Extracorporeal Irradiation: Co-60, Sr-90, and Y-90
Internal Radiation Sources:
- Infusion: Au-198 and P-32
- Interstitial Implant: I-125 and Ir-192
- Selectively Absorbed or Concentrated: P-32, I-131, and Y-90
2. Diagnostic Applications
| Diagnostic Purpose | Radio Pharmaceuticals |
|---|---|
| Brain Imaging | Tc-99m labelled lipophilic agents, Ceretec, Neurolite |
| Thyroid Imaging | I-131 sodium iodide |
| Heart Imaging | TI-201 chloride, Tc-99m labelled agents |
| Gastric Imaging | Tc-99m SC, Tc-99m RBC, Tc-99m IDA compounds |
| Bone Imaging | Tc-99m phosphate compounds |
| Pulmonary Imaging | Tc-99m DTPA, Xe-133 gas, Tc-99m labelled MAA |
| Renal Imaging | Tc-99m labelled agents for filtration, secretion, and morphology |
| Infection Imaging | Tc-99m or In-111 labelled white blood cells, Ga-67 |
| Tumour Imaging | Ga-67, F-18 FDG (PET imaging) |
| Bone Pain Palliation | Sr-89, Sm-153 |
Dpharmguru’s exam insights:
Diagnostic applications of radiopharmaceuticals are frequently tested. Remember the key isotopes: Tc-99m is the workhorse for most imaging (brain, heart, bone, renal). I-131 is used for thyroid imaging and therapy. F-18 FDG is the gold standard for PET tumour imaging. TI-201 is used for myocardial perfusion imaging. Know the indications for each!
6.2. RADIOACTIVE WASTE
One type of hazardous trash that includes radioactive substances is called radioactive waste, which is generally produced in any nuclear innovation. Nuclear medicine, nuclear exploration, nuclear force, production, development, coal and rare-earth mining, and nuclear weapons reprocessing are among the industries producing radioactive waste.
6.2.1. Classification of Radioactive Wastes
- High-level Waste: Contains 95% of total radioactivity. Highly hazardous, requires cooling and isolation. Examples: Spent nuclear fuel, reprocessing waste.
- Intermediate-level Waste: Contains 4% of radioactivity. Requires shielding during handling and storage. Examples: Resins, chemical sludges, metal fuel cladding.
- Low-level Waste: Contains ~90% of all nuclear waste by volume but only 1% of radioactivity. Examples: Contaminated clothing, tools, medical waste.
- Transuranic Waste: Contains more than 3700 becquerels per gram of elements heavier than uranium. Examples: Waste from nuclear weapons production.
- Mining and Milling Waste: Produced during mining activities. Examples: Tailings, contaminated soil.
6.2.2. Radioactive Waste Management
Reducing the total amount of waste produced is one of the most current objectives with regard to radioactive waste. Standard methods for ensuring proper handling and treatment include:
- Incineration: Commercially-operated incinerators burn radioactive waste, primarily low-level waste consisting of contaminated clothing and other materials.
- Storage (Radioactive Decay): Storing waste until it is no longer radioactive. Effective for waste with shorter half-lives.
- Shallow Burial: Used for mill tailings. The pile is coated with a non-permeable material to prevent erosion.
- Deep Burial (Geological Disposal): The most common method for high-level waste. Material is buried deep inside the earth.
- In Water: Used at nuclear sites for storing spent fuel in specially designed pools or ponds.
- Recycling: Certain radioactive elements like uranium and plutonium can be recovered and reused.
- The Ocean: Small amounts of liquid waste may be dumped into the ocean after extensive treatment.
- Seabed Disposal: Burying waste deep within the seabed—now largely discontinued due to international agreements.
- Long-term Aboveground Storage Bunkers: Temporary solutions designed for accessibility for reuse or decomposition.
Dpharmguru’s exam insights:
Radioactive waste management is a critical topic. Remember the classification: High-level (95% radioactivity), Intermediate-level (4%), and Low-level (1% radioactivity but 90% of volume). Disposal methods include incineration, storage, shallow/deep burial, and recycling. The concept of “Delay, Dilute and Disperse, Concentrate and Contain, Recycle and Reuse” is the guiding philosophy in India.
FREQUENTLY ASKED QUESTIONS (FAQs)
1. What is the most commonly used radio pharmaceutical?
Technetium-99m (Tc-99m) is the most commonly used radio pharmaceutical. It has a half-life of 6 hours, emits 140 keV gamma rays, and is widely available from a molybdenum-99 generator.
2. What is the difference between diagnostic and therapeutic radio pharmaceuticals?
Diagnostic radio pharmaceuticals use radiation to create images of the body’s internal structures, while therapeutic radio pharmaceuticals use radiation to destroy abnormal cells like cancer cells. Diagnostic doses are much lower than therapeutic doses.
3. What are “cold kits” in nuclear pharmacy?
Cold kits are ready-to-use kits containing all non-radioactive ingredients needed for a radiopharmaceutical. They are reconstituted by adding the radionuclide at the time of intended use, allowing for convenient preparation.
4. What safety precautions are required when handling radio pharmaceuticals?
Key precautions include: using rubber gloves, avoiding mouth-operated pipettes, using forceps, using shielding devices, preventing contamination, and prohibiting eating, drinking, or smoking in the work area.
5. How is radioactive waste classified?
Radioactive waste is classified into high-level (95% of radioactivity), intermediate-level (4%), low-level (1% of radioactivity but 90% of volume), transuranic waste, and mining/milling waste.
6. What is the role of a pharmacist in nuclear medicine?
The nuclear pharmacist is responsible for the safe preparation, compounding, dispensing, storage, and disposal of radiopharmaceuticals. They also ensure quality control, proper labelling, and radiation safety.
SUMMARY
Radio pharmaceuticals are a unique and vital class of drugs that combine pharmaceutical compounds with radioactive materials for diagnostic and therapeutic purposes. Understanding their ideal characteristics, handling procedures, storage requirements, dispensing protocols, and disposal methods is essential for any nuclear pharmacy professional.
The diagnostic applications of radiopharmaceuticals are extensive—from brain imaging and cardiac perfusion studies to bone scans and tumour localisation. Therapeutic applications utilise the destructive properties of radiation to treat cancers and other proliferative disorders. Tc-99m remains the most versatile and commonly used radionuclide in diagnostic nuclear medicine.
Radioactive waste management requires careful attention to classification and disposal methods to protect human health and the environment. The guiding philosophy in India—Delay, Dilute and Disperse, Concentrate and Contain, Recycle and Reuse—ensures safe and responsible management of radioactive materials.
As I always tell my students: “Nuclear pharmacy is not just about handling radioactive materials—it is about using radiation safely and effectively to save lives through accurate diagnosis and targeted therapy.”
REFERENCES AND FURTHER READING
- Pharmacy Council of India (PCI). (2022). Nuclear Pharmacy Guidelines. New Delhi: PCI.
- International Atomic Energy Agency (IAEA). (2022). Radiopharmaceuticals: Production and Quality Control. Retrieved from https://www.iaea.org.
- World Health Organization (WHO). (2022). Guidelines on Radiopharmaceuticals. Retrieved from https://www.who.int.
- Atomic Energy Regulatory Board (AERB). (2022). Safety Guidelines for Handling Radiopharmaceuticals. Government of India.
- American Pharmacists Association (APhA). (2022). Nuclear Pharmacy Practice Standards. Retrieved from https://www.pharmacist.com.
- Saha, G. B. (2018). Fundamentals of Nuclear Pharmacy (7th ed.). Springer.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Nuclear pharmacy regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.
written by:
Dr. N. Sujith Kumar
For More Study Materials, Visit: www.dpharmguru.com
